Phase II Study of Gemcitabine Plus Paclitaxel in Metastatic Breast Cancer Patients with Prior Anthracycline Exposure

Author： Demiray Mutlu   Kurt Ender   Evrensel Turkkan   Kanat Ozkan   Arslan Murat   Saraydaroglu Ozlem   Ercan Ilker   Gonullu Guzin   Gokgoz Sehsuvar   Topal Ugur   Tolunay Sahsine   Tasdelen Ismet   Manavoglu Osman  

Publisher： Informa Healthcare

ISSN： 0735-7907

Source： Cancer Investigation, Vol.23, Iss.5, 2005-07, pp. : 386-391

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II study of weekly gemcitabine in patients with metastatic breast cancer relapsing or failing both an anthracycline and a taxane

By Smorenburg C.H.   Bontenbal M.   Seynaeve C.   Zuylen C.v.   Heus G.d.   Verweij J.   Wit R.d.  

Breast Cancer Research and Treatment, Vol. 66, Iss. 1, 2001-03 ,pp. : 83-87

Springer Publishing Company

Access to resources Recommend Favorite

Phase II, double-blind, randomized trial of capecitabine plus enzastaurin versus capecitabine plus placebo in patients with metastatic or recurrent breast cancer after prior anthracycline and taxane therapy

By Clemons Mark   Joy Anil   Abdulnabi Radhi   Kotliar Mauricio   Lynch Jodi   Jordaan Johan   Iscoe Neill   Gelmon Karen  

Breast Cancer Research and Treatment, Vol. 124, Iss. 1, 2010-11 ,pp. : 177-186

Springer Publishing Company

Access to resources Recommend Favorite

Capecitabine plus paclitaxel as front-line combination therapy for metastatic breast cancer: a multicenter phase II study

By  

The Women's Oncology Review, Vol. 4, Iss. 4, 2004-12 ,pp. : 283-285

Informa Healthcare

Access to resources Recommend Favorite

A multicenter phase II study of TSU-68, a novel oral multiple tyrosine kinase inhibitor, in patients with metastatic breast cancer progressing despite prior treatment with an anthracycline-containing regimen and taxane

By Suzuki Yasuhiro   Saeki Toshiaki   Aogi Kenjiro   Toi Masakazu   Fujii Hirofumi   Inoue Kenichi   Watanabe Toru   Fujiwara Yasuhiro   Ito Yoshinori   Takatsuka Yuichi   Iwata Hiroji   Arioka Hitoshi   Tokuda Yutaka  

International Journal of Clinical Oncology, Vol. 18, Iss. 4, 2013-08 ,pp. : 590-597

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer

By Song Hong   Do Young   Chang Heung   Ryu Min   Lee Kyung   Kim Yeul   Hong Dae   Cho Jae   Lee Kyoung   Kim Si  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 5, 2008-10 ,pp. : 763-768

Springer Publishing Company

Access to resources Recommend Favorite